Incidence of and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis: National Data from Japan

被引:77
作者
Harada, Kenichi [1 ]
Hirohara, Junko [2 ]
Ueno, Yoshiyuki [3 ]
Nakano, Toshiaki [4 ]
Kakuda, Yuko [1 ]
Tsubouchi, Hirohito [5 ]
Ichida, Takafumi [6 ]
Nakanuma, Yasuni [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan
[2] Kansai Med Univ, Dept Internal Med 3, Osaka, Japan
[3] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan
[4] Kansai Med Univ, Univ Informat Ctr, Osaka, Japan
[5] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Kagoshima 890, Japan
[6] Juntendo Univ, Sch Med, Shizuoka Hosp, Div Gastroenterol & Hepatol, Izunokuni, Japan
关键词
EXTRAHEPATIC MALIGNANCIES; AUTOIMMUNE HEPATITIS; GENDER DISPARITY; SURVIVAL; PROGRESSION; PROGNOSIS; FEATURES; CANCER; PBC;
D O I
10.1002/hep.26176
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Primary biliary cirrhosis (PBC) primarily affects females and is rarely complicated by hepatocellular carcinoma (HCC). Although the HCC incidence in PBC patients is low, several characteristics and risk factors associated with its development have been reported. In this study, national data concerning the current status of carcinogenesis in PBC patients in Japan are reviewed. Using data from two national questionnaire surveys, we investigated the clinicopathological findings associated with HCC in PBC patients. According to the data of all reviewed PBC patients, the HCC incidence was 2.4% (71/2946). The HCC incidence by gender was 5.1% (19/370) in males and 2.0% (52/2576) in females, and the proportion of males was 26.7%. Prognosis was significantly poorer in the PBC patients with HCC than in those without. Multivariate analysis of risk factors associated with HCC by gender revealed histological stage at the time of PBC diagnosis as an independent risk factor associated with the development of HCC in females, but not in males. Furthermore, data from another national survey of 178 PBC patients with HCC (male/female = 49/129; proportion of males 27.5%) revealed that the duration between the diagnosis of PBC and that of HCC was significantly shorter in males than in females. In addition, histological stage at the time of HCC diagnosis was an independent risk factor for HCC in females, whereas no risk factors were identified in males. Conclusion: these data indicate that males are at risk of developing HCC at any histological stage of PBC. Therefore, male PBC patients in particular should be carefully screened for HCC from the early stages of PBC. (HEPATOLOGY 2013;57:1942-1949)
引用
收藏
页码:1942 / 1949
页数:8
相关论文
共 24 条
[1]
Caballería L, 2001, AM J GASTROENTEROL, V96, P1160
[2]
Incidence, Risk Factors, and Survival of Hepatocellular Carcinoma in Primary Biliary Cirrhosis: Comparative Analysis from Two Centers [J].
Cavazza, Anna ;
Caballeria, Llorenc ;
Floreani, Annarosa ;
Farinati, Fabio ;
Bruguera, Miquel ;
Caroli, Diego ;
Pares, Albert .
HEPATOLOGY, 2009, 50 (04) :1162-1168
[3]
Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis [J].
Deutsch, Melanie ;
Papatheodoridis, George V. ;
Tzakou, Anastasia ;
Hadziyannis, Stephanos J. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (01) :5-9
[4]
Findor Jorge, 2002, Autoimmunity Reviews, V1, P220, DOI 10.1016/S1568-9972(02)00050-2
[5]
FLOREANI A, 1993, ITAL J GASTROENTEROL, V25, P473
[6]
Harada K, 1997, HEPATOLOGY, V26, P1399
[7]
Jones DEJ, 1997, HEPATOLOGY, V26, P1138
[8]
Hepatocellular carcinoma in a male patient with early stage (stage I) primary biliary cirrhosis [J].
Kadokawa, Y ;
Omagari, K ;
Ohba, K ;
Kitamura, S ;
Ohara, H ;
Takeshima, F ;
Mizuta, Y ;
Nanashima, A ;
Yamaguchi, H ;
Kohno, S .
INTERNAL MEDICINE, 2005, 44 (03) :207-211
[9]
Medical progress: Primary biliary cirrhosis [J].
Kaplan, MM ;
Gershwin, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1261-1273
[10]
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis [J].
Miyake, Y. ;
Iwasaki, Y. ;
Terada, R. ;
Okamaoto, R. ;
Ikeda, H. ;
Makino, Y. ;
Kobashi, H. ;
Takaguchi, K. ;
Sakaguchi, K. ;
Shiratori, Y. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (08) :1197-1205